参考文献/References:
1 Aarsland D, Andersen K, Larsen J P, et al. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Archives of Neurology, 2003, 60(3): 387-392.
2 Mamikonyan E, Moberg P J, Siderowf A, et al. Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination(MMSE)scores. Parkinsonism & Related Disorders, 2009, 15(3): 226-231.
3 Petersen R C. Mild cognitive impairment as a diagnostic entity. Journal of Internal Medicine, 2004, 256(3): 183-194.
4 Wada K, Nakashima K. [Mild cognitive impairment in Parkinson's disease]. Brain and Nerve= Shinkei Kenkyu no Shinpo, 2012, 64(12): 1365-1375.
5 Litvan I, Goldman J G, Tr ster A I, et al. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines. Movement Disorders, 2012, 27(3): 349-356.
6 Goldman J G, Holden S, Bernard B, et al. Defining optimal cutoff scores for cognitive impairment using movement disorder society task force criteria for mild cognitive impairment in Parkinson's disease. Movement Disorders, 2013, 28(14): 1972-1979.
7 Biswal B, Zerrin Yetkin F, Haughton V M, et al. Functional connectivity in the motor cortex of resting human brain using echo-planar mri. Magnetic Resonance in Medicine, 1995, 34(4): 537-541.
8 Melrose RJ, Poulin RM, Stern CE. An fMRI investigation of the role of the basal ganglia in reasoning. Brain research, 2007, 1142(1): 146-158.
9 Ekman U, Eriksson J, Forsgren L, et al. Longitudinal changes in task-evoked brain responses in Parkinson's disease patients with and without mild cognitive impairment. Frontiers in Neuroscience, 2014, 8(207):1-10.
10 Bai F, Zhang Z, Yu H, et al. Default-mode network activity distinguishes amnestic type mild cognitive impairment from healthy aging: a combined structural and resting-state functional MRI study. Neuroscience Letters, 2008, 438(1): 111-115.
11 Baggio H C, Segura B, Sala-Llonch R, et al. Cognitive impairment and resting-state network connectivity in Parkinson's disease. Human Brain Mapping, 2015, 36(1): 199-212.
12 Kwak Y, Peltier S, Bohnen N, et al. Altered resting state cortico-striatal connectivity in mild to moderate stage Parkinson's disease. Frontiers in Systems Neuroscience, 2010, 4(143):1-25.
13 Baggio HC, Sala-Llonch R, Segura B, et al. Functional brain networks and cognitive deficits in Parkinson's disease. Human brain mapping,2014,9(35):4620 4634.
14 Zhang B, Li M, Sun Z Z, et al. Evaluation of functional MRI markers in mild cognitive impairment. Journal of clinical neuroscience, 2009, 16(5): 635-641.
15 Fayed N, D vila J, Oliveros A, et al. Utility of different MR modalities in mild cognitive impairment and its use as a predictor of conversion to probable dementia. Academic Radiology, 2008, 15(9): 1089-1098.
16 Zhu D, Shen D, Jiang X, et al. Connectomics signature for characterizaton of mild cognitive impairment and schizophrenia[C]//Biomedical Imaging(ISBI), 2014 IEEE 11th International Symposium on. IEEE, 2014: 325-328.
17 陈燕生, 方元, 史文宗, 等. 早期帕金森病黑质致密部 FA 值量化研究. 放射学实践, 2014,29(4):387-389.
18 李飞平, 沈加林, 许建荣, 等. 弥散张量成像对早期帕金森病的研究价值. 中国医学计算机成像杂志, 2010, 16(4): 273-276.
19 Kamagata K, Tomiyama H, Hatano T, et al. A preliminary diffusional kurtosis imaging study of Parkinson disease: comparison with conventional diffusion tensor imaging. Neuroradiology, 2014, 56(3): 251-258.
20 Falangola M F, Jensen J H, Tabesh A, et al. Non-Gaussian diffusion MRI assessment of brain microstructure in mild cognitive impairment and Alzheimer's disease. Magnetic Resonance Imaging, 2013, 31(6): 840-846.
21 Lee J E, Cho K H, Kim M, et al. The pattern of cortical atrophy in Parkinson's disease with mild cognitive impairment according to the timing of cognitive dysfunction. Journal of Neurology, 2012, 259(3): 469-473.
22 Weintraub D, Doshi J, Koka D, et al. Neurodegeneration across stages of cognitive decline in Parkinson disease. Archives of Neurology, 2011, 68(12): 1562-1568.
23 Song SK, Lee JE, Park H J, et al. The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status. Movement Disorders, 2011, 26(2): 289-296.
24 Melzer T R, Watts R, MacAskill M R, et al. Grey matter atrophy in cognitively impaired Parkinson's disease. Journal of Neurology, Neurosurgery & Psychiatry, 2012, 83(2): 188-194.
25 陈德强, 贺 丹. 磁敏感加权成像技术原理及临床应用进展. 脑与神经疾病杂志, 2009, 17(2): 152-154.
26 Braak H, Tredici K D, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging, 2003, 24(2): 197-211.
27 Hodaie M, Neimat J S, Lozano A M. The Dopaminergic Nigrostriatal Systemand Parkinson's Disease: Molecular Eventsin Development, Disease, and Cell Death, and New Therapeutic Strategies. Neurosurgery, 2007, 60(1): 17-30.
28 王 慈,范国光,等.SWI 鉴别帕金森病和帕金森综合征的研究进展. 国际医学放射学杂志, 2011,34(1):24-27.
29 Wu S F, Zhu Z F, Kong Y, et al. Assessment of cerebral iron content in patients with Parkinson's disease by the susceptibility-weighted MRI. European Review for Medical and Pharmacological Sciences, 2014, 18(18): 2605-2608.
30 Tumati S, Martens S, Aleman A. Magnetic resonance spectroscopy in mild cognitive impairment: Systematic review and meta-analysis. Neuroscience & Biobehavioral Reviews, 2013, 37(10): 2571-2586.
31 Nie K, Zhang Y, Huang B, et al. Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment. Parkinsonism & Related Disorders, 2013, 19(3): 329-334.
32 Targosz-Gajniak MG, Siuda JS, Wicher MM, et al. Magnetic resonance spectroscopy as a predictor of conversion of mild cognitive impairment to dementia. Journal of the neurological sciences, 2013, 335(1): 58-63.
33 Pagonabarraga J, G mez-Ans n B, Rotger R, et al. Spectroscopic Changes Associated with Mild Cognitive Impairment and Dementia in Parkinson's Disease. Dementia and Geriatric Cognitive Disorders, 2012, 34(5-6): 312-318.
34 Chao LL, Buckley ST, Kornak J, et al. ASL perfusion MRI predicts cognitive decline and conversion from MCI to dementia. Alzheimer Dis Assoc Disord,2010,24(1):19-27.
35 Ding B, Ling H, Zhang Y, et al. Pattern of cerebral hyperperfusion in Alzheimer's disease and amnestic mild cognitive impairment using voxel-based analysis of 3D arterial spin-labeling imaging: initial experience. Clinical Interventions in Aging, 2014, 9: 493.
36 Binnewijzend MAA, Kuijer JPA, Benedictus MR, et al. Cerebral blood flow measured with 3D pseudocontinuous arterial spin-labeling MR imaging in Alzheimer disease and mild cognitive impairment: a marker for disease severity. Radiology, 2013, 267(1): 221-230.